Publications

Dans le cadre de CKD-REIN :

• Villain C et al. Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors with Aging in Patients with Chronic Kidney Disease: a Propensity Score Analysis. JAMDA accepté.
• Hamroun A, et al. New Insights into Acute-on-Chronic Kidney Disease in Nephrology Patients: The CKD-REIN Study. Nephrol Dial Transplant. 2021 Sep 2:gfab249. doi: 10.1093/ndt/gfab249. Online ahead of print.
• Alencar de Pinho N, et al. Réalité de la prise en charge de la maladie rénale chronique en néphrologie en France – Etude de cohorte CKD-REIN. Nephrol Ther. 2021 Aug 10;S1769-7255(21)00146-2. doi: 10.1016/j.nephro.2021.06.008. Online ahead of print
• Massy ZA, et al. Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort study. J Nephrol. 2021 Oct;34(5):1467-1477.
• Laville SM, et al. Consequences of oral antithrombotic use in patients with chronic kidney disease. Clin Transl Sci. 2021 Jun 3. doi: 10.1111/cts.13084. Online ahead of print
• Fages V, et al. Urgent-start dialysis in patients referred early to a nephrologist – The CKD-REIN prospective cohort study. Nephrol Dial Transplant. 2021 May 4;gfab170. doi: 10.1093/ndt/gfab170. Online ahead of print.
• Wagner S, et al. Water intake and progression of chronic kidney disease - The CKD-REIN Cohort Study. Nephrol Dial Transplant. 2021 Feb 12:gfab036. doi: 10.1093/ndt/gfab036. Online ahead of print.
• Liabeuf S et al. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease. Br J Clin Pharmacol. 2020. doi: 10.1111/bcp.14713. Online ahead of print. (in press)
• Montalescot L et al. Reliability and validity of the French adaptation of the Family Relationship Index-short form in patients’ with chronic kidney disease. J Health Psychol. 2020 Aug 10;1359105320949921.
• Alencar de Pinho N et al. Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD. Kidney Int Rep. 2020 Aug;5(8):1240–50.
  • Alencar de Pinho N, Massy ZA, Druëke T, Stengel B. Response to sodium and potassium intake: a new statistical model to test their effects on health outcomes. Kidney Int Rep. 2020;5(12):2403-2404.
• Laville SM et al. Adverse Drug Reactions in Patients with CKD. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1090-1102.
• Cheddani L et al. Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results. Nephrol Dial Transplant. 2021 Jan 1;36(1):176-184
• Legrand K, et al. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France. Am J Kidney Dis Off J Natl Kidney Found. 2020;75(6):868–78.
• Massy ZA, et al. Achievement of low-density lipoprotein cholesterol targets in chronic kidney disease: the CKD-REIN cohort study. Kidney Int Rep. 2019;4(11):1546–54.
• Villain C, et al. Impact of age on cardiovascular drug use in patients with chronic kidney disease. Clin Kidney J. 2020;13(2):199–207.
• Schweitzer ML, et al. Obesity phenotype and patient-reported outcomes in moderate and advanced chronic kidney disease. A cross-sectional study from the CKD-REIN cohort study. Qual Life Res. 2019;28(7):1873-1883.
• Villain C, et al. Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in CKD. Nephrol Dial Transplant. 2020;35(5):827-836.
• Laville SM, et al. Evaluation of the adequacy of drug prescriptions in patients with CKD - CKD-REIN cohort. Br J Clin Pharmacol, 2018; 84: 2811-23
• Stengel et al. Risk profile, quality of life and care of patients with CKD - The French CKD-REIN cohort study. Nephrol Dial Transplant. 2019;34:277–86.
• Balkau B, et al. Impact of sex and glucose-lowering treatments on hypoglycemic symptoms in patients with T2D and CKD. Diabetes Metab. 2019;45(2):175–83.
• Affret A et al. Validity and reproducibility of a short food frequency questionnaire among patients with chronic kidney disease. BMC Nephrol. 2017 Sep 15;18(1):297.
• Stengel B, et al. [The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study: To better understand chronic kidney disease]. Nephrol Ther. 2016 Apr;12 Suppl 1:S49-56.
• Stengel B, et al. The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Nephrol Dial Transplant 2014 Aug;29(8):1500–7.

Dans le cadre de l'étude internationale CKDopps : 

• Zee J, et al. Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps. Kidney Medicine (2021).
• Liabeuf S, et al. Prescription of direct oral anticoagulants to patients with moderate-to-advanced CKD: too little or just right? Kidney International Reports (2021) 6, 2496–2500.
• Guedes M et al. Serum biomarkers of iron stores are associated with an Increased Risk of All-Cause Mortality and Cardiovascular Events in Non-Dialysis Chronic Kidney Disease Patients, With or Without Anemia. J Am Soc Nephrol. 2021 Aug;32(8):2020-2030.
• Guedes M et al. Serum biomarkers of iron stores are associated with worse physical health-related quality of life (HRQoL) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients with or without anemia. Nephrol Dial Transplant. 2021;36:1694–1703.
• Stengel B, et al. Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries. Kidney Int Rep. 2020;6(2):437-448
• Reichel H et al. Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2020;35(5):803-810
• Sophie Liabeuf, et al. International Variation in the Management of Serum Vitamin D and Mineral Bone Disorder in Patients with Chronic Kidney Disease: Results from CKDopps. Bone. 2019;129:115058.
• Wong MM, et al. Anemia and Iron Deficiency Among CKD Stage 3-5 ND Patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: Often Unmeasured, Variably Treated. Clin Kidney J. 2020 Aug 1;13(4):613–24.
• Pecoits-Filho R, et al. Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care. J Clin Hypertens Greenwich Conn. 2019 Jul;21(7):991-1001.
• Sukul N, et al. Pruritus and Patient Reported Outcomes in Non-Dialysis Chronic Kidney Disease. 2019 May; 14(5):673-681.
• Mariani L et al. The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods. Am J Kidney Dis. 2016 Sep;68(3):402-13 

Dans le cadre de la collaboration avec le réseau iNET-CKD :

• Alencar de Pinho N, et al. Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease. Kidney Int. 2019 Oct;96(4):983-994.
• Dienemann T et al. International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts. BMC Nephrol.2016 Sep 2;17(1):121.

Autres collaborations internationales : 

• Zacharias H. et al. A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests. Am J Kidney Dis. 2021 Jul 11;S0272-6386(21)00729-0. doi: 10.1053/j.ajkd.2021.05.018. Online ahead of print.